Suite 1220 - 789 West Pender Street
Vancouver, British Columbia V6C 1H2
Phone: 604-683-3995/Toll Free: 888-945-4770
CAVAN VENTURES INC. COMPLETES MINI-BULK SAMPLE AND AWAITING ASSAY AND PURITY RESULTS FROM SGS CANADA INC. (LAKEFIELD) LAB
April 8tht, 2015, Vancouver, BC, Canada - Cavan Ventures Inc. ("Cavan" or the "Company") (CVN - TSX.V) is pleased to announce the completion of a sampling program consisting of two 20kg mini- bulk samples from its high grade Buckingham Graphite property in Southern Quebec at the request of Caribou King Resources ltd.(CKR-TSX.V).
The first sample was taken from T-1 trench which previously returned 11% org.c from Channel sampling results. The second sample was taken from 22c trench which previously returned 25% org.c from channel sampling results. (See news release July 8th, 2014).
This mini-bulk sample will be sent to SGS Canada Inc. (Lakefield) lab for purity testing. The company expects assay and purity results in the coming weeks.
President and CEO Peter Swistak states, "We are extremely pleased with the efficiency and quick completion of our mini-bulk sample work program. We are looking forward to receiving the assay and purity results in the coming weeks. We are excited to further advance our high grade Buckingham property and to continue to create value for our shareholders.
The technical contents of this release were approved by Case Lewis P. Geo. and a qualified person as defined by National Instrument 43-101.
Cavan's mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. For more information visit the website at www.cavanventuresinc.com.
ON BEHALF OF THE BOARD
Peter P. Swistak, President
Forward-Looking Statement: Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's plans with respect to its existing graphite interests, future financings, and the analysis and investigation of the medical marijuana sphere. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future and statements concerning the anticipated drilling programs, future
financings, and the Company proceeding with any transactions in the medical marijuana sphere. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they
do occur, what benefits the Company will obtain from them. In particular, the Company cautions that any financings or potential transactions cannot be predicted with certainty, and there can be no assurance at this time that all required or desirable approvals and consents to affect future financings or proposed transactions will be achieved at all. These forward-looking statements reflect management's current views and are based on certain expectations and assumptions
which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including factors beyond the Company's control. These forward-looking statements are made as of the date of this news release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.